Poor prognosis indicators of type-2 diabetic COVID-19 patients

Detalhes bibliográficos
Autor(a) principal: Gorjão,R.
Data de Publicação: 2022
Outros Autores: Hirabara,S.M., Masi,L.N., Serdan,T.D.A., Gritte,R.B., Hatanaka,E., Souza-Siqueira,T., Pithon-Curi,A.C., Lima,T.M. de, Pithon-Curi,T.C., Marchini,J.F.M., Machado,M.C.C., Souza,H.P., Curi,R.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100638
Resumo: Diabetes is associated with a worse prognosis and a high risk of morbidity and mortality in COVID-19 patients. We aimed to evaluate the main factors involved in the poor prognosis in diabetic patients. A total of 984 patients diagnosed with COVID-19 admitted to the hospital were included in this study. Patients were first divided into type-2 diabetic (DM+) and non-diabetic (DM–) groups. The participants were analyzed based on the National Early Warning Score (NEWS) and on the Quick-Sequential Organ Failure Assessment (qSOFA) to find the best prognostic risk score for our study. The DM+ and DM– groups were divided into non-severe and severe groups. Comparative and correlative analyses were used to identify the physiological parameters that could be employed for creating a potential risk indicator for DM+ COVID-19 patients. We found a poorer prognosis for the DM+ COVID-19 patients with a higher ICU admission rate, mechanical ventilation rate, vasopressor use, dialysis, and longer treatment times compared with the DM– group. DM+ COVID-19 patients had increased plasma glucose, lactate, age, urea, NEWS, and D-dimer levels, herein referred to as the GLAUND set, and worse prognosis and outcomes when compared with infected DM– patients. The NEWS score was a better indicator for assessing COVID-19 severity in diabetic patients than the q-SOFA score. In conclusion, diabetic COVID-19 patients should be assessed with the NEWS score and GLAUND set for determining their prognosis COVID-19 prognosis.
id ABDC-1_d4b7ad11ce6add10f20eacb3d26056df
oai_identifier_str oai:scielo:S0100-879X2022000100638
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Poor prognosis indicators of type-2 diabetic COVID-19 patientsSARS-CoV-2C-reactive proteinLactateUreaD-dimerNEWSDiabetes is associated with a worse prognosis and a high risk of morbidity and mortality in COVID-19 patients. We aimed to evaluate the main factors involved in the poor prognosis in diabetic patients. A total of 984 patients diagnosed with COVID-19 admitted to the hospital were included in this study. Patients were first divided into type-2 diabetic (DM+) and non-diabetic (DM–) groups. The participants were analyzed based on the National Early Warning Score (NEWS) and on the Quick-Sequential Organ Failure Assessment (qSOFA) to find the best prognostic risk score for our study. The DM+ and DM– groups were divided into non-severe and severe groups. Comparative and correlative analyses were used to identify the physiological parameters that could be employed for creating a potential risk indicator for DM+ COVID-19 patients. We found a poorer prognosis for the DM+ COVID-19 patients with a higher ICU admission rate, mechanical ventilation rate, vasopressor use, dialysis, and longer treatment times compared with the DM– group. DM+ COVID-19 patients had increased plasma glucose, lactate, age, urea, NEWS, and D-dimer levels, herein referred to as the GLAUND set, and worse prognosis and outcomes when compared with infected DM– patients. The NEWS score was a better indicator for assessing COVID-19 severity in diabetic patients than the q-SOFA score. In conclusion, diabetic COVID-19 patients should be assessed with the NEWS score and GLAUND set for determining their prognosis COVID-19 prognosis.Associação Brasileira de Divulgação Científica2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100638Brazilian Journal of Medical and Biological Research v.55 2022reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431x2022e11819info:eu-repo/semantics/openAccessGorjão,R.Hirabara,S.M.Masi,L.N.Serdan,T.D.A.Gritte,R.B.Hatanaka,E.Souza-Siqueira,T.Pithon-Curi,A.C.Lima,T.M. dePithon-Curi,T.C.Marchini,J.F.M.Machado,M.C.C.Souza,H.P.Curi,R.eng2022-06-15T00:00:00Zoai:scielo:S0100-879X2022000100638Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2022-06-15T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Poor prognosis indicators of type-2 diabetic COVID-19 patients
title Poor prognosis indicators of type-2 diabetic COVID-19 patients
spellingShingle Poor prognosis indicators of type-2 diabetic COVID-19 patients
Gorjão,R.
SARS-CoV-2
C-reactive protein
Lactate
Urea
D-dimer
NEWS
title_short Poor prognosis indicators of type-2 diabetic COVID-19 patients
title_full Poor prognosis indicators of type-2 diabetic COVID-19 patients
title_fullStr Poor prognosis indicators of type-2 diabetic COVID-19 patients
title_full_unstemmed Poor prognosis indicators of type-2 diabetic COVID-19 patients
title_sort Poor prognosis indicators of type-2 diabetic COVID-19 patients
author Gorjão,R.
author_facet Gorjão,R.
Hirabara,S.M.
Masi,L.N.
Serdan,T.D.A.
Gritte,R.B.
Hatanaka,E.
Souza-Siqueira,T.
Pithon-Curi,A.C.
Lima,T.M. de
Pithon-Curi,T.C.
Marchini,J.F.M.
Machado,M.C.C.
Souza,H.P.
Curi,R.
author_role author
author2 Hirabara,S.M.
Masi,L.N.
Serdan,T.D.A.
Gritte,R.B.
Hatanaka,E.
Souza-Siqueira,T.
Pithon-Curi,A.C.
Lima,T.M. de
Pithon-Curi,T.C.
Marchini,J.F.M.
Machado,M.C.C.
Souza,H.P.
Curi,R.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Gorjão,R.
Hirabara,S.M.
Masi,L.N.
Serdan,T.D.A.
Gritte,R.B.
Hatanaka,E.
Souza-Siqueira,T.
Pithon-Curi,A.C.
Lima,T.M. de
Pithon-Curi,T.C.
Marchini,J.F.M.
Machado,M.C.C.
Souza,H.P.
Curi,R.
dc.subject.por.fl_str_mv SARS-CoV-2
C-reactive protein
Lactate
Urea
D-dimer
NEWS
topic SARS-CoV-2
C-reactive protein
Lactate
Urea
D-dimer
NEWS
description Diabetes is associated with a worse prognosis and a high risk of morbidity and mortality in COVID-19 patients. We aimed to evaluate the main factors involved in the poor prognosis in diabetic patients. A total of 984 patients diagnosed with COVID-19 admitted to the hospital were included in this study. Patients were first divided into type-2 diabetic (DM+) and non-diabetic (DM–) groups. The participants were analyzed based on the National Early Warning Score (NEWS) and on the Quick-Sequential Organ Failure Assessment (qSOFA) to find the best prognostic risk score for our study. The DM+ and DM– groups were divided into non-severe and severe groups. Comparative and correlative analyses were used to identify the physiological parameters that could be employed for creating a potential risk indicator for DM+ COVID-19 patients. We found a poorer prognosis for the DM+ COVID-19 patients with a higher ICU admission rate, mechanical ventilation rate, vasopressor use, dialysis, and longer treatment times compared with the DM– group. DM+ COVID-19 patients had increased plasma glucose, lactate, age, urea, NEWS, and D-dimer levels, herein referred to as the GLAUND set, and worse prognosis and outcomes when compared with infected DM– patients. The NEWS score was a better indicator for assessing COVID-19 severity in diabetic patients than the q-SOFA score. In conclusion, diabetic COVID-19 patients should be assessed with the NEWS score and GLAUND set for determining their prognosis COVID-19 prognosis.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100638
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100638
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1414-431x2022e11819
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.55 2022
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302948973740032